Related references
Note: Only part of the references are listed.Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors
Ferah Comert Onder et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Discovery of Lysine-Targeted eIF4E Inhibitors through Covalent Docking
Xiaobo Wan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
A comparative study of small molecules targeting eIF4A
Sai Kiran Naineni et al.
RNA (2020)
Roles of eIF3m in the tumorigenesis of triple negative breast cancer
Wei Han et al.
CANCER CELL INTERNATIONAL (2020)
Robust landscapes of ribosome dwell times and aminoacyl-tRNAs in response to nutrient stress in liver
Cedric Gobet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer
Jiehong Kong et al.
ONCOTARGETS AND THERAPY (2020)
Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma
Steffen Fuchs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer
Tung H. Ng et al.
BMC CANCER (2019)
A novel rapamycin analog is highly selective for mTORC1 in vivo
Katherine H. Schreiber et al.
NATURE COMMUNICATIONS (2019)
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
Chang-Kyu Heo et al.
SCIENTIFIC REPORTS (2019)
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment
Dennis Heinzen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency
Chien-Ju Chen et al.
NATURE MEDICINE (2019)
Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway
Shi-long Jiang et al.
ACTA PHARMACOLOGICA SINICA (2019)
Therapeutic Targeting of mTORC2 in mTORopathies
Brianne Dentel et al.
NEURON (2019)
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Sangita Sridharan et al.
FRONTIERS IN ONCOLOGY (2019)
eIF3a: A new anticancer drug target in the eIF family
Ji-Ye Yin et al.
CANCER LETTERS (2018)
Translation initiation factors and their relevance in cancer
Columba de la Parra et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer
Yongzhi Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102
Noah Kornblum et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
Siegfried H. Reich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis
Aya El Khodiry et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Translation Elongation and Recoding in Eukaryotes
Thomas E. Dever et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
RNA binding protein 24 regulates the translation and replication of hepatitis C virus
Huang Cao et al.
PROTEIN & CELL (2018)
Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
Jens C. Hahne et al.
FRONTIERS IN ONCOLOGY (2018)
UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
Sajjad Hussain et al.
BLOOD (2018)
Translation acrobatics: how cancer cells exploit alternate modes of translational initiation
Ashwin Sriram et al.
EMBO REPORTS (2018)
MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
Xian-bo Huang et al.
ACTA PHARMACOLOGICA SINICA (2018)
mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells
Stacia L. Koppenhafer et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma
Michael Cerezo et al.
NATURE MEDICINE (2018)
ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay
Marisa Kamelgarn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro
Yi-di Guan et al.
ACTA PHARMACOLOGICA SINICA (2018)
Interaction of p190A RhoGAP with eIF3A and Other Translation Preinitiation Factors Suggests a Role in Protein Biosynthesis
Prasanna Parasuraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Cellular mRNA recruits the ribosome via eIF3-PABP bridge to initiate internal translation
Nehal Thakor et al.
RNA BIOLOGY (2017)
A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis
Annelise Carvalho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis
Pin Liu et al.
HEPATOLOGY (2017)
Regulation of mRNA Translation in Neurons-A Matter of Life and Death
Mridu Kapur et al.
NEURON (2017)
Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
Q. Wang et al.
ONCOGENE (2017)
The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment
Gaelan Melanson et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma
Hongcheng Zhu et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells
Y. J. Choi et al.
BONE & JOINT RESEARCH (2017)
Targeting of protein translation as a new treatment paradigm for prostate cancer
Vidya P. Ramamurthy et al.
CURRENT OPINION IN ONCOLOGY (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5-Terminal Cap and Hairpin
Nadejda L. Korneeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Michal Grzmil et al.
CELLULAR SIGNALLING (2016)
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Aude De Gassart et al.
EMBO REPORTS (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
Y. Cheng et al.
ONCOGENE (2016)
Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Jennifer Chu et al.
TRENDS IN CELL BIOLOGY (2016)
CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway
Qiuyuan Wen et al.
ONCOTARGET (2016)
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
Alexandria T. Phan et al.
CANCER MEDICINE (2016)
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Jiaoyan Han et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Targeting the eIF4A RNA helicase as an anti-neoplastic approach
Jennifer Chu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Mnks, eIF4E phosphorylation and cancer
Christopher G. Proud
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma
Yao Zhan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression
Amy S. Y. Lee et al.
NATURE (2015)
eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation
Yu Zhang et al.
ONCOTARGET (2015)
Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors
H. Jean Khoury et al.
LEUKEMIA & LYMPHOMA (2015)
The Scanning Mechanism of Eukaryotic Translation Initiation
Alan G. Hinnebusch
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α
Ji Cao et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Elongation factor 2 diphthamide is critical for translation of two IRES-dependent protein targets, XIAP and FGF2, under oxidative Stress conditions
Sandro Argueelles et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells
Esther Z. Chen et al.
INVESTIGATIONAL NEW DRUGS (2014)
Eukaryotic Elongation Factor 2 Kinase Activity Is Controlled by Multiple Inputs from Oncogenic Signaling
Xuemin Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Lise Boussemart et al.
NATURE (2014)
Synthesis, Pharmacophores, and Mechanism Study of Pyridin-2(1H)-one Derivatives as Regulators of Translation Initiation Factor 3A
Weixing Zhu et al.
ARCHIV DER PHARMAZIE (2013)
Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells
Yan Cheng et al.
AUTOPHAGY (2013)
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
I. Ray-Coquard et al.
BRITISH JOURNAL OF CANCER (2013)
Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients
Xiaojing Xu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Translation Initiation Factor eIF3b Expression in Human Cancer and Its Role in Tumor Growth and Lung Colonization
Hong Wang et al.
CLINICAL CANCER RESEARCH (2013)
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
Xiaojing Xu et al.
LUNG CANCER (2013)
Regulation of protein translation initiation in response to ionizing radiation
Donatella Trivigno et al.
RADIATION ONCOLOGY (2013)
Pharmacological targeting of eIF4E in primary CLL lymphocytes
V. Martinez-Marignac et al.
BLOOD CANCER JOURNAL (2013)
Small-molecule targeting of translation initiation for cancer therapy
Bertal H. Aktas et al.
ONCOTARGET (2013)
Investigating the Kinetic Mechanism of Inhibition of Elongation Factor 2 Kinase by NH125: Evidence of a Common in Vitro Artifact
Ashwini K. Devkota et al.
BIOCHEMISTRY (2012)
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
Qingshan Yang et al.
BLOOD (2012)
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Thomas Bachelot et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Elongation, Termination, and Recycling Phases of Translation in Eukaryotes
Thomas E. Dever et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments
Ji-Ye Yin et al.
BIOSCIENCE REPORTS (2011)
Oncogenic AKTivation of translation as a therapeutic target
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2011)
Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
Ji-Ye Yin et al.
CLINICAL CANCER RESEARCH (2011)
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens
B. C. Kraljacic et al.
LEUKEMIA (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cap and cap-binding proteins in the control of gene expression
Ivan Topisirovic et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Targeting the translational machinery as a novel treatment strategy for hematologic malignancies
Patrick R. Hagner et al.
BLOOD (2010)
The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival
Matthew J. Wheater et al.
CANCER BIOLOGY & THERAPY (2010)
Compensatory activation of Akt in response to mTOR and Raf inhibitors - A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
Kathrin Zitzmann et al.
CANCER LETTERS (2010)
Negative Regulatory Effects of Mnk Kinases in the Generation of Chemotherapy-Induced Antileukemic Responses
Jessica K. Altman et al.
MOLECULAR PHARMACOLOGY (2010)
The mechanism of eukaryotic translation initiation and principles of its regulation
Richard J. Jackson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway
Karine Villaume et al.
NEUROENDOCRINOLOGY (2010)
Cytoprotective Effect of the Elongation Factor-2 Kinase-Mediated Autophagy in Breast Cancer Cells Subjected to Growth Factor Inhibition
Yan Cheng et al.
PLOS ONE (2010)
Nontoxic Chemical, Interdiction of the Epithelial-to-Mesenchymal Transition by Targeting Cap-Dependent Translation
Brahma Ghosh et al.
ACS CHEMICAL BIOLOGY (2009)
Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction
Patrick R. Hagner et al.
BLOOD (2009)
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
Sarit Assouline et al.
BLOOD (2009)
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity
L. J. Coleman et al.
BRITISH JOURNAL OF CANCER (2009)
Homoharringtonine, Omacetaxine Mepesuccinate, and Chronic Myeloid Leukemia Circa 2009
Alfonso Quintas-Cardama et al.
CANCER (2009)
Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
Bojie Dai et al.
CANCER RESEARCH (2009)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Akt-dependent and -independent mechanisms of mTOR regulation in cancer
Regan M. Memmott et al.
CELLULAR SIGNALLING (2009)
Structural basis for translational inhibition by the tumour suppressor Pdcd4
Portia G. Loh et al.
EMBO JOURNAL (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163
Susan L. Ellard et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer
Arzu Umar et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Structural Mechanism of Substrate RNA Recruitment in H/ACA RNA-Guided Pseudouridine Synthase
Jingqi Duan et al.
MOLECULAR CELL (2009)
The elF3 Interactome Reveals the Translasome, a Supercomplex Linking Protein Synthesis and Degradation Machineries
Zhe Sha et al.
MOLECULAR CELL (2009)
Altering Chemosensitivity by Modulating Translation Elongation
Francis Robert et al.
PLOS ONE (2009)
Crystal structure of the eIF4A-PDCD4 complex
Jeong Ho Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Translation Initiation Factor 4E (eIF4E): Prognostic Marker and Potential Therapeutic Target
Funda Meric-Bernstam
ANNALS OF SURGICAL ONCOLOGY (2008)
Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
Tobias Schmid et al.
CANCER RESEARCH (2008)
Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
Andrea Bianchini et al.
CARCINOGENESIS (2008)
Mammalian target of rapamycin as a therapeutic target in oncology
Robert T. Abraham et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)
Maria Buxade et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance
Min Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms
Wolf Peter Hofmann et al.
LIVER INTERNATIONAL (2008)
MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA
A. Phillips et al.
ONCOGENE (2008)
The PUA domain -: a structural and functional overview
Isabel Perez-Arellano et al.
FEBS JOURNAL (2007)
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G
Nathan J. Moerke et al.
CELL (2007)
S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N. Valerio Dorrello et al.
SCIENCE (2006)
MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles
Line S. Reinert et al.
CANCER RESEARCH (2006)
Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells
J. Shi et al.
ONCOGENE (2006)
In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3
Elena Z. Alkalaeva et al.
CELL (2006)
Stopped-flow kinetic analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped oligoribonucleotides - Evidence for a one-step binding mechanism
Sergey V. Slepenkov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2
J Ling et al.
EMBO JOURNAL (2005)
MCT-1 oncogene contributes to increased In vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis
AS Levenson et al.
CANCER RESEARCH (2005)
Inhibition of translational initiation by Let-7 microRNA in human cells
RS Pillai et al.
SCIENCE (2005)
A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress
M Boyce et al.
SCIENCE (2005)
eIF-4E expression and its role in malignancies and metastases
A De Benedetti et al.
ONCOGENE (2004)
eIF4E - from translation to transformation
Y Mamane et al.
ONCOGENE (2004)
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells
WH Mondesire et al.
CLINICAL CANCER RESEARCH (2004)
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
D Ruggero et al.
NATURE MEDICINE (2004)
EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression
ZZ Dong et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies
B Shi et al.
BLOOD (2003)
The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation
HS Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA
GC Scheper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evidence for the transforming activity of a truncated Int6 gene, in vitro
SB Rasmussen et al.
ONCOGENE (2001)
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
XM Wang et al.
EMBO JOURNAL (2001)
Unified nomenclature for the subunits of eukaryotic initiation factor 3
KS Browning et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation
HS Yang et al.
ONCOGENE (2001)
Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase
SI Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
Share Paper
